Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
10.51
+0.44 (4.37%)
At close: Aug 4, 2026, 4:00 PM EDT
10.40
-0.11 (-1.05%)
Pre-market: Aug 5, 2026, 4:32 AM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $770.07 million as of August 5, 2026. Its market cap has increased by 129.59% in one year.
Market Cap
770.07M
Enterprise Value
624.51M
1-Year Change
129.59%
Ranking
Category
Stock Price
$10.51
ChartMarket Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $770.07M, an increase of 246.27%. That is a compound annual growth rate of 28.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 770.07M | 148.27% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 763.27M |
| Aclaris Therapeutics | 748.60M |
| SpyGlass Pharma | 735.53M |
| Monopar Therapeutics | 730.17M |
| Phathom Pharmaceuticals | 727.58M |
| Oculis Holding AG | 723.75M |
| Bright Minds Biosciences | 721.25M |
| Nuvectis Pharma | 715.79M |